The size of the Middle East and Africa Anti Snoring Devices Market is to value USD 0.13 Billion by 2029 and was worth USD 0.21 Billion in 2024, growing at a CAGR of 9.35%.
The rise in the number of older people population and lifestyle changes in the community are key driving factors for the anti-snoring devices market to grow. Rising demand for advanced technology and the introduction of innovative products are fuelling the need of the market.
Creating awareness over the devices through campaigns and digital advertisements is also surging the growth rate of the market. Rising disposable income in urban areas is promoting the demand of the market.
However, people in rural areas are less aware of these devices, and this factor is slowly hindering the demand of the market. The availability of other devices is also impeding the growth rate of the market. Stringent rules and regulations by government organizations in approving new products may also impact negatively on the growth of this market. Growing issues with the usage of these devices are hampering the growth of the market in this region.
In this region, the factors that are responsible for the growth are an increase in population and a high adoption rate of the treatment device. The emergence of the latest technology and on-going R&D activities are mainly to escalate the growth of the market in this region.
Top Companies leading the Middle East & Africa Anti Snoring Devices Market Profiled in the Report are Sleeping Well LLC, Apnea Sciences Corporation, Tomed Dr Toussaint Gmbh, AccuMED Corp, Fisher & Paykel Healthcare, ImThera Medical Inc., ResMed Inc., SomnoMed, Sleep Well Enjoy Life, Ltd., MEDiTAS Ltd and Nasal Devices.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region